Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 12, 2012, Pages 1170-1173

  Décard, Bernhard F ^a   Von Ahsen, Nicolas ^b   Grunwald, Thomas ^c   Streit, Frank ^b   Stroet, Anke ^a   Niggemeier, Petra ^d   Schottstedt, Volkmar ^d   Riggert, Joachim ^e   Gold, Ralf ^a   Chan, Andrew ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d Central Lab   (Germany)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; EPSTEIN BARR VIRUS ANTIGEN 1; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMYELINATING DISEASE; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

ADULT; AGE OF ONSET; BLOOD DONORS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GERMANY; HERPESVIRUS 4, HUMAN; HUMANS; HYDROXYCHOLECALCIFEROLS; IMMUNOGLOBULIN G; MALE; MULTIPLE SCLEROSIS; TANDEM MASS SPECTROMETRY; VITAMIN D DEFICIENCY;

EID: 84869239818     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303068     Document Type: Article

References (14)

1. Lonergan R, Kinsella K, Fitzpatrick P, et al. Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry 2011;82:317-22.
2. Lassmann H, Niedobitek G, Aloisi F, et al. Epstein-Barr virus in the multiple sclerosis brain: a controversial issu - dreport on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 2011;134:2772-86.
3. Farrell RA, Antony D, Wall GR, et al. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 2009;73:32-8.
4. Soilu-Hänninen M, Laaksonen M, Laitinen I, et al. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008;79:152-7. (Pubitemid 351236545)
5. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-8. (Pubitemid 44969183)
6. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001;286:3083-8. (Pubitemid 34016522)
7. Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005;293:2496-500. (Pubitemid 40705731)
8. Munger KL, Levin LI, O'Reilly EJ, et al. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler 2011;17:1185-93.
9. Sundström P, Juto P, Wadell G, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004;62:2277-82. (Pubitemid 38787787)
10. Chan A, Decard BF, Franke C, et al. Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis. Mult Scler 2010; 16:1189-92.
11. Hintzpeter B, Mensink GB, Thierfelder W, et al. Vitamin D status and health correlates among German adults. Eur J Clin Nutr 2008;62:1079-89.
12. Handel AE, Giovannoni G, Ebers GC, et al. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010;6:156-66.
13. Levin LI, Munger KL, O'Reilly EJ, et al. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010;67:824-30.
14. Disanto G, Meier U, Giovannoni G, et al. Vitamin D: a link between Epstein-Barr virus and multiple sclerosis development? Expert Rev Neurother 2011; 11:1221-4.